275 related articles for article (PubMed ID: 3116199)
1. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
2. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
Shriver DA; Katz LB; Rosenthale ME
Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
5. Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
Katz LB; Shriver DA
J Pharmacol Exp Ther; 1989 Nov; 251(2):774-81. PubMed ID: 2509683
[TBL] [Abstract][Full Text] [Related]
6. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Katz LB; Tobia AJ; Shriver DA
J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
Gaginella TS; Müller RK; Witt CG; Rosen P; Holland GW; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):202-7. PubMed ID: 2578188
[TBL] [Abstract][Full Text] [Related]
8. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
[TBL] [Abstract][Full Text] [Related]
9. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
Morris GP; Keenan CM; Shriver DA
Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
[TBL] [Abstract][Full Text] [Related]
10. Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effects.
Katz LB; Shriver DA
Toxicol Appl Pharmacol; 1989 Oct; 101(1):36-46. PubMed ID: 2508266
[TBL] [Abstract][Full Text] [Related]
11. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
12. Altered susceptibility of arthritic rats to the gastric lesion-inducing effects of aspirin or ethanol and the antilesion effect of rioprostil.
Katz LB; Genna T; Fuller BL; Tolman EL; Shriver DA
Agents Actions; 1987 Oct; 22(1-2):134-43. PubMed ID: 3120518
[TBL] [Abstract][Full Text] [Related]
13. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
[TBL] [Abstract][Full Text] [Related]
14. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
[TBL] [Abstract][Full Text] [Related]
15. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
17. Rioprostil prevents gastric bleeding induced by nonsteroidal antiinflammatory drugs in dogs and arthritic rats.
Katz LB; Capetola RJ; Argentieri DC; Moore LE; Genna T; Porter MC; Jasty V; Hartnagel RE; Abrutyn D; Shriver DA
J Rheumatol; 1986 Oct; 13(5):887-94. PubMed ID: 3102726
[TBL] [Abstract][Full Text] [Related]
18. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
Katz LB; Genna T; Greeley GH; Shriver DA
Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
[TBL] [Abstract][Full Text] [Related]
19. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
20. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
